Stocktoria
Caribou Biosciences, Inc. CRBU
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2021-07-23
Chart by TradingView
2/9
Piotroski F — financial health
-9.88
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Revenue | $11.2M | $10.0M | $34.5M | $13.9M | $9.6M |
| Operating income | -$148.3M | -$166.6M | -$116.1M | -$106.4M | -$67.0M |
| Net income | -$148.1M | -$149.1M | -$102.1M | -$99.4M | -$66.9M |
| Operating cash flow | -$111.0M | -$138.2M | -$93.3M | -$91.0M | -$32.5M |
| Free cash flow | -$112.4M | -$143.1M | -$104.9M | -$97.4M | -$34.6M |
| Total assets | $175.4M | $313.3M | $432.2M | $373.8M | $442.4M |
| Total liabilities | $53.2M | $60.4M | $63.8M | $72.9M | $54.5M |
| Shareholders' equity | $122.2M | $253.0M | $368.4M | $300.9M | $387.8M |
| Ratios | |||||
| Operating margin | -1329.4% | -1667.2% | -336.6% | -768.2% | -697.8% |
| Net margin | -1327.4% | -1491.9% | -296.1% | -717.8% | -697.3% |
| FCF margin | -1006.8% | -1431.7% | -304.3% | -703.3% | -360.9% |
| Return on assets | -84.5% | -47.6% | -23.6% | -26.6% | -15.1% |
| Return on equity | -121.2% | -58.9% | -27.7% | -33.0% | -17.3% |
| Current ratio | 5.71 | 7.16 | 11.97 | 9.25 | 15.15 |
| Revenue growth | 11.7% | -71.0% | 148.9% | 44.3% | -22.4% |
Notable holders (13F)
| Investor | Shares | Value |
|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 2,590,497 | $4.9M |
| Point72 Asset Management, L.P. | 187,622 | $356,482 |
Why these scores methodology →
Piotroski F-score: 2/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: -9.88 (distress)
- Working capital / assets 0.683
- Retained earnings / assets -3.402
- EBIT / assets -0.846
- Equity / liabilities 2.297
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001619856 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.